您的位置: 首页 > 农业专利 > 详情页

Leczenie nowotworu złośliwego za pomocą humanizowanego chimerycznego receptora antygenowego anty-egfrviii
专利权人:
The Trustees Of The University Of Pennsylvania;Novartis AG;University of Pittsburgh - Of the Commonwealth System of Higher Education
发明人:
BROGDON, JENNIFER,LOEW, ANDREAS,JOHNSON, LAURA ALEXANDRA,JUNE, CARL H.,MAUS, MARCELA,SCHOLLER, JOHN,OKADA, HIDEHO
申请号:
PL14713280
公开号:
PL2958943T3
申请日:
2014.02.20
申请国别(地区):
PL
年份:
2020
代理人:
摘要:
The invention provides compositions and methods for treating diseases associated with expression of EGFRvIII. The invention also relates to chimeric antigen receptor (CAR) specific to EGFRvIII, vectors encoding the same, and recombinant T cells comprising the anti-EGFRvIII CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an anti-EGFRvIII binding domain.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充